Fierce JPM Week - Virtual Agenda has ended
Back To Schedule
Tuesday, January 18 • 9:30am - 10:30am
New paths to trial diversity

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

To get drug development done through COVID-19 lockdowns and social distancing, trial sponsors turned to new technology—from data management to patient monitoring—and decentralized procedures. Those same methods could potentially help biopharma bring real diversity to future clinical trials. But hurdles to these patient-centric trials still remain. How can drugmakers clear those obstacles and tap technology to make their trials look like the patient populations who’ll use the treatments being tested? 

avatar for Annalee Armstrong

Annalee Armstrong

Senior Editor, Fierce Biotech
Annalee Armstrong is a senior editor for Fierce Biotech. Prior to joining Fierce in April 2021, Annalee was an associate editor for S&P Global Market Intelligence’s healthcare news team. Before that, she was the EPA reporter covering climate and energy policy on the Hill in Washington... Read More →

avatar for Jessica L. Mega, M.D.

Jessica L. Mega, M.D.

Co-Founder and Chief Medical and Scientific Officer, Verily
Jessica L. Mega, MD, MPH, is the Co-Founder and Chief Medical and Scientific Officer at Verily. As CMSO, Dr. Mega's focus is on translating technological innovations and scientific insights into partnerships and programs that improve patient outcomes and healthcare. She oversees all... Read More →
avatar for Keiki Oishi

Keiki Oishi

President and COO, CMIC Group
Ms. Oishi is the President and COO of CMIC HOLDINGS Co., Ltd., responsible for group-wide business execution.Ms. Oishi received her Master of Science degree from the University of Tokyo. She started her career at Nikkei McGraw-Hill, Inc. in Japan (now renamed Nikkei Business Publications... Read More →
avatar for Gaelan Ritter

Gaelan Ritter

Head of Analytics Innovation and Digital Health, Bristol-Myers Squibb
As the head of Analytics Innovation and Digital Health, Gaelan and his team are responsible for leading cutting edge real-world data alliances and most importantly creating and developing innovations across R&D. He co-leads the BMS digital innovation pillar for global drug development... Read More →
avatar for Gregory Rotz

Gregory Rotz

Principal, PwC US
Greg Rotz is a Principal with PwC and leads the transformation consulting practice focused on Pharmaceuticals and Life Sciences (PLS). He brings nearly 25 years of experience shaping and serving the C-suite agenda for his clients.In his sector leadership role, Greg’s focus is to... Read More →
avatar for Ramona Sequeira

Ramona Sequeira

President, U.S. Business Unit and Global Portfolio Commercialization, Takeda Pharmaceuticals
Ramona Sequeira is President of Takeda’s US Business Unit and Global Portfolio Commercialization. She serves as a member of Takeda’s global Executive Team.Ramona joined Takeda in 2015. Through her work with Takeda and, prior to that, with Eli Lilly and Company, she has more than... Read More →
avatar for Craig Tendler, M.D.

Craig Tendler, M.D.

Global Head, Late-Stage Clinical Development, Diagnostics & Medical Affairs, Hematology & Oncology, Janssen
Craig Tendler, M.D. is Vice President, Oncology Clinical Development and Global Medical Affairs at Janssen Research & Development, LLC. In this position, he is responsible for creating robust development plans and data generation activities for all therapies in the oncology portfolio... Read More →

Tuesday January 18, 2022 9:30am - 10:30am EST